"The US Food and Drug Administration (FDA) today approved asfotase alfa (Strensiq, Alexion Pharmaceuticals) as the first-ever therapy for patients who develop hypophosphatasia, a rare metabolic bone disorder, in childhood.
Synagis Patient Information including If I Miss a Dose
In this Article
- What is palivizumab (Synagis)?
- What are the possible side effects of palivizumab (Synagis)?
- What is the most important information I should know about palivizumab (Synagis)?
- What should I discuss with my healthcare provider before receiving palivizumab (Synagis)?
- How is palivizumab given (Synagis)?
- What happens if I miss a dose (Synagis)?
- What happens if I overdose (Synagis)?
- What should I avoid while receiving palivizumab (Synagis)?
- What other drugs will affect palivizumab (Synagis)?
- Where can I get more information?
What happens if I miss a dose (Synagis)?
Since this medication is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.
Call your doctor for instructions if you miss an appointment for your child's palivizumab injection.
What happens if I overdose (Synagis)?
Seek emergency medical attention if you think your child has received too much of this medicine.
Symptoms of a palivizumab overdose are not known.
What should I avoid while receiving palivizumab (Synagis)?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
What other drugs will affect palivizumab (Synagis)?
There may be other drugs that can interact with palivizumab. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Where can I get more information?
Your doctor or pharmacist can provide more information about palivizumab.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2013 Cerner Multum, Inc. Version: 3.01. Revision date: 7/30/2012.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Synagis Information
Synagis - User Reviews
Synagis User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.